Endocrine Signalling From Adipose Tissue (5/6) Flashcards

1
Q

What is the Randle Hypothesis?

A

Mechanism of inhibition of glucose utilization by fatty acid oxidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does endocrine signalling from adipose tissue change in obesity?

A

The release of FFA and pro-inflammatory cytokines is increased due to the increased size in adipose tissue
This causes an influx to other organs and fat accumulation there
Increased glucose output from the liver
Decreased glucose uptake by muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does fatty acid oxidation inhibit glucose utilisation?

A

Acetyl-CoA is produced from fatty acid oxidation and glycolysis
It is converted into citrate which moves into the cytoplasm
Citrate can be converted back into acetyl-CoA and then malonyl-CoA
However, it can also inhibit GLUT4 (glucose uptake) and PFK-1 (glycolysis enzyme)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does an overload of glucose and/or fatty acids cause?

A

Excess energy production
Overproduction of acetyl-CoA
This inhibits glucose uptake and causes an increased uptake of fat in muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is the action of malonyl-CoA implicated in obesity?

A

In healthy tissue malonyl-CoA inhibits CPT1
In obesity, too much fat is entering the cells - overwhelms malonyl-CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What causes muscle insulin resitance?

A

Genes
Aging
Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does muscle insulin resistance lead to?

A

β-cell compensation (hyperinsulinemia), then decompensation (some die)
Increased lipolysis in visceral fat (FA increase)
Increased gluconeogenesis in the liver (glucose output increase)

Together, these lead to impaired glucose tolerance -> decreased insulin secretion -> diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does insulin binding to its receptor cause?

A

Insulin interacts with the α-subunits of its receptor
This increases the autophosphorylation and the tyrosine kinase activity of the β-subunits
It phosphorylates docking proteins:
-SHC
-IRS1
-APS (PH and SH2 domains)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does the phosphorylation of docking protein SHC activate in insulin signalling?

A

Recruitment of the Grb2–SOS
MAPK pathway activated
Ras -> Raf -> MEK -> MAPK -> cell growth/ gene expression regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does the phosphorylation of docking protein IRS1 activate in insulin signalling?

A

Association between PI3-kinase (PI3K) and IRS-1 increases the amount of PI3P
This activates PDK1 and its effectors: the Ser/Thr kinases PKB and atypical PKCζ
These kinases are involved in the stimulation of glucose uptake
PKB is also involved in insulin-induced glycogen synthesis- phosphorylatesm(inactivates) glycogen synthase kinase-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the phosphorylation of docking protein APS activate in insulin signalling?

A

APS and the CAP–Cbl complex interact, allowing the tyrosine phosphorylation of Cbl by the insulin receptor
This mediates glucose transport by a pathway dependent on the activation of the small GTPase TC10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does fatty acid accumulation affect insulin receptor substrate 1 (IRS1)?

A

Increased FFAs activate JNK and PKCθ
JNK phosphorylates Ser 307 (also activated by insulin but increased with FFA presence)
PKCθ alternatively phosphorylates at Ser612 and Ser632 (insulin phosphorylates Tyr608 and Tyr628) - less affinity for PI3K if alternatively phosphorylated- more insulin needed for same signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is ceramide produced in response to?

A

Stress stimuli including in obesity (e.g., chemotherapy, inflammatory agonists, saturated fatty acids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is ceramide synthesised?

A

By a de novo biosynthesis from precursor palmitate

Through the activation of inflammatory pathways triggered by TLR4 recognition of saturated fatty acids, which induce the upregulation of genes driving ceramide biosynthesis

Through the breakdown of more-complex sphingolipids as part of a “salvage pathway”

Through the disruption of endoplasmic reticulum homeostasis (ER stress)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is ceramide synthesis regulation implicated in diabetes?

A

The action of adiponectin at AdipoR1/AdipoR2 receptors activate their ceramidase activity which decreases ceramide production by converting it into sphingosine.
In diabetes, adiponectin levels are decreased.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does ceramide accumulation lead to?

A

Impaired cellular function, including insulin action

Ceramide directly activates PKCζ isoform which phosphorylates and inhibits the translocation of Akt/PKB
Stimulates the activity of a cytosolic protein phosphatase 2A (PP2A)- phosphatase that dephosphorylating Akt/PKB
Induce further ER stress and mitochondrial dysfunction

17
Q

What cells are common in lean adipose tissue?

A

M2 macrophages
Th2 cells
Tregs
iNKT cells
Eosinophils

18
Q

What cells are common in obese adipose tissue?

A

Increased influx of monocytes
Proinflammatory M1 macrophages
Th1 cells
Th17 cells
Neutrophils
B cells

19
Q

What happens to adipocytes in obesity?

A

They become overloaded with fat burst -> cell death

20
Q

What are the 2 types of macrophages?

A

M1: pro-inflammatory
M2: anti-inflammatory

21
Q

What changes occur in adipose tissue in obesity?

A

Lean adipose: type 2 environment - type 2 cytokines: IL-4, IL-5, and IL-13, cell surface molecule interactions

Obesity: type 1 inflammation due to activation of M1 macrophages etc.
Increase of saturated fatty acids, AT hypoxia, danger-associated molecular patterns (DAMPs), and metabolic endotoxemia with increased plasma levels of lipopolysaccharide (LPS)

22
Q

What is the difference between white and beige adipocytes?

A

White adipocytes: store fat
Beige adipocytes: generate heat in cold conditions

23
Q

What happens to the number of white and beige adipocytes in obesity?

A

Decrease in beige adipocytes due to change in cytokines released

24
Q

What is dysfunctional adipose remodelling?

A

When beige adipogenesis is suppressed and insulin resistance is induced

25
Q

Which receptors detect TNFα?

A

TNFR1 (mainly) and TNFR2

25
Q

Which adipokine levels change in obesity?

A

Decrease in adiponectin
Increase in TNF-α and IL-6

26
Q

What is TNFα?

A

Pro-inflammatory cytokine synthesised in adipocytes
26kDa precursor - cleaved to 17kDa

27
Q

What does TNFα do in obesity?

A

Promotes insulin resistance

28
Q

What are the effects of elevated TNFα levels?

A

Increase FFA levels
Increase hepatic triglyceride production
Downregulate GLUT-4
Inhibit insulin receptor autophosphorylation and IRS-1 tyrosyl phosphorylation
Increase IRS-1 serine/threonine phosphorylation- causes alternate phosphorylation of IRS through activation of mTOR: decreases signal transduction
Inhibit PPARγ synthesis and/or function and impair adipocyte function via NFkB activation

29
Q

What happens in TNFα signalling?

A

Sphingomyelinase activation
Increase fats (e.g., ceramide)

30
Q

What happens in insulin-mediated glucose uptake?

A

Insulin -> activates insulin receptor (autophosphorylates) -> PI3K -> PDK -> AKT -> GLUT4 translocates to membrane -> glucose uptake

31
Q

What is the role of IL-6?

A

Activates pro-inflammatory cytokines
Also activates SOCS: silencer of cytokine signalling

32
Q

What is the role of SOCS3?

A

Inhibits insulin signalling:
Binds to phosphorylated JAK and insulin receptor IR
Can also bind to elongin which ubiquitinated IRS1 and 2: degradation
Less insulin signal transduction

33
Q

What is adiponectin?

A

Anti-inflammatory action – blocks TNFα activation of NFκB by blocking IκB phosphorylation
Reduces hepatic glucose and triglyceride output
Increases muscle and liver fatty acid oxidation reducing insulin resistance

34
Q

What is the role of adiponectin in skeletal muscle?

A

AdipoR1/AdipoR2 -> APPL1/APPL2 -> enhance fatty acid oxidation through MAPK-PPARα-mediated expression and activation of ACOX1 and AMPK-NAD+/NADH-mediated response of ACC

Activated AdipoR1/AdipoR2 also increase mitochondrial biogenesis through APPL1-SERCA-Ca2+-CaMKKβ or LKB1-AMPK-NAD+/NADH-SIRT1-mediated activation of PGC1α

Activation of adiponectin receptors enhances glucose uptake via APPL1-Rab5 or APPL1-AMP-AMPK-mediated translocation of GLUT4 as well as attenuation of Rheb-mTOR-S6K1-induced inhibition of insulin signalling

35
Q

What is the role of adiponectin and AdipoR1 in the liver?

A

AdipoR1 activates AMPK via APPL1/LKB1 or APPL1/PLC/Ca2+/CaMKK mediated signalling pathways

Activated AMPK:
Inhibits the activities of PEPCK and G6Pase through the activation of EGR1 and DUSP4, which leads to decreased gluconeogenesis
Also decreases lipid biosynthesis through inhibiting sterol regulatory element-binding transcription factor 1c (SREBP1c)-mediated transcription of acetyl-CoA carboxylase (ACC), FAS and stearoyl-CoA desaturase (SCD)1
Increases abnormality in mitochondrial morphologies and fatty acid oxidation via sequestering the inhibitory effect of ACC-1 on carnitine palmitoyltransferase (CPT)-1 activation

36
Q

What is the role of adiponectin and AdipoR2 in the liver?

A

AdipoR2 activates:
Fatty acid oxidation through PPARα-induced activation of acyl-CoA oxidase (ACO) and uncoupling protein (UCP)2
Adiponectin also protects hepatocytes through the inhibition of ROS-mediated activation of proinflammatory molecules including TNF-α and MCP1

37
Q

How does adiponectin relate to insulin?

A

Adiponectin increases insulin sensitivity through the activation of AdipoR1/R2 following CDase-mediated degradation of ceramides